Abstract Body

Binding of the gp120 envelope glycoprotein to the CD4 receptor is the first step in the HIV-1 infectious cycle. Although the CD4-binding site has been extensively characterized by mutagenesis and co-crystallization with soluble CD4 (sCD4), most of these studies were performed with monomeric gp120 subunits, thus hindering the evaluation of the role of quaternary elements that may be involved in the initial CD4 interaction. Moreover, the initial receptor interaction has been difficult to study because of major CD4-induced structural rearrangements.

The DS-SOSIP.664 trimer, 4-domain CD4, and PGT145 Fab were expressed in 293FS cells and purified for cryogenic electron microscopy (cryo-EM) analysis; data were acquired using the Leginon system installed on a Krios electron microscope operating at 300kV; for ELISA and SPR, wild-type (WT) and mutated SOSIP trimers and gp120 monomers were expressed in 293FS and extensively purified; WT and mutated full-length gp160 were expressed in 293T cells for flow cytometry and co-transfected with an HIV-1 backbone plasmid to produce infectious pseudoviruses; infectivity assays were performed in TZMbl cells.

Cryo-EM analysis of the stabilized DS-SOSIP.664 trimer, which remains in a pre-fusion closed conformation after interaction with CD4, permitted to visualize the initial contact with CD4 at 6.8-Å resolution. We found that the initial CD4-contact site in the HIV-1 Env trimer is constituted by a quaternary surface formed by coalescence of the previously defined CD4-binding region in the outer domain of one gp120 protomer with a second CD4-binding site (CD4-BS2) that encompasses discontinuous elements from the inner domain of a neighboring gp120 protomer. Disruption of CD4-BS2 destabilized CD4-trimer interaction and abrogated HIV-1 infectivity by preventing acquisition of coreceptor-binding competence. A corresponding reduction in HIV-1 infectivity occurred upon mutation of CD4 residues that interact with CD4-BS2. Quaternary interactions were also documented for selected neutralizing antibodies to the CD4 supersite, providing evidence that the CD4-BS2 region is immunogenic in vivo.

These results document the critical role of quaternary interactions in the initial HIV-1 envelope-receptor contact, with implications for treatment and vaccine design.